Observational Study on Dynamic Changes of Blood Pressure During Post-epileptic Seizure Stage (OCBPS)
1 other identifier
observational
1,100
1 country
1
Brief Summary
This article details a multicenter study on changes of blood pressure and heart rate during post-epileptic seizure stage.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 18, 2025
CompletedFirst Posted
Study publicly available on registry
January 24, 2025
CompletedStudy Start
First participant enrolled
January 26, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2026
CompletedApril 9, 2026
April 1, 2026
1.2 years
January 18, 2025
April 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparison of baseline blood pressure versus post-epileptic seizure blood pressure (systolic and diastolic)
Baseline blood pressure and blood pressure measurements (systolic and diastolic) immediately after seizure (0-1 minute), at 3 minutes (2-4 minutes), 5 minutes (4-6 minutes), 10 minutes (9-11 minutes), 20 minutes (19-21 minutes), 30 minutes (29-31 minutes), and 60 minutes (59-61 minutes) post-seizure.
within 1 hour
Secondary Outcomes (2)
Comparison of baseline heart rate versus post-epileptic seizure heart rate
within 1 hour
Comparison of baseline blood-oxygen versus post-epileptic seizure blood-oxygen
within 1 hour
Eligibility Criteria
Inpatient epilepsy patients
You may qualify if:
- Age 14-80 years old, male and female;
- Meet the diagnostic criteria for epilepsy, including focal epilepsy and generalized epilepsy.
- Patients diagnosed with epilepsy, with at least one seizure during the hospitalization.
- Seizures lasting longer than 30 seconds (including convulsive and non-convulsive status epilepticus, if seizure cessation can be determined and medications were recorded, they can be included).
- Hypertensive patients who are on antihypertensive medication and have well-controlled blood pressure are eligible.
- Patients who agree to participate in the study.
You may not qualify if:
- Patients with structural heart disease, coronary artery disease (CAD), cardiomyopathy
- Patients with severe systemic diseases
- Pregnancy
- Preictal seizures or myoclonic seizures.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Xuanwu Hospital, Beijinglead
- Fujian Medical University Union Hospitalcollaborator
- The First Hospital of Hebei Medical Universitycollaborator
- Henan Provincial People's Hospitalcollaborator
- The First Hospital of Jilin Universitycollaborator
- The First Affiliated Hospital with Nanjing Medical Universitycollaborator
- General Hospital of Ningxia Medical Universitycollaborator
- The Affiliated Hospital of Qingdao Universitycollaborator
- Shandong Provincial Hospitalcollaborator
- Ruijin Hospital Luwan Branchcollaborator
- Shenzhen University General Hospitalcollaborator
- Beijing Sanbo Brain Hospitalcollaborator
- Xuanwu Jinan Hospitalcollaborator
- First Affiliated Hospital Xi'an Jiaotong Universitycollaborator
- First Affiliated Hospital of Zhejiang Universitycollaborator
- The First Affiliated Hospital of Zhengzhou Universitycollaborator
- The First Affiliated Hospital of China University of Science and Technology (Anhui Provincial)collaborator
- Peking Union Medical College Hospitalcollaborator
- First Affiliated Hospital, Sun Yat-Sen Universitycollaborator
- The Affiliated Hospital of Xuzhou Medical Universitycollaborator
Study Sites (1)
Liankun Ren, MD
Beijing, Beijing Municipality, 100053, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Liankun Ren, MD
Study Principal Investigator
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 18, 2025
First Posted
January 24, 2025
Study Start
January 26, 2025
Primary Completion
March 31, 2026
Study Completion
March 31, 2026
Last Updated
April 9, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share